Drug intelligence / Profile preview

Hims Hard Mints

Development stage
Unknown
Lead developer
Hims & Hers Health
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral (chewable Tablet)
01

Overview

Hims Hard Mints are prescription-only, chewable, mint-flavored compounded tablets formulated to treat erectile dysfunction (ED). They can contain one or more phosphodiesterase type 5 (PDE5) inhibitors—most commonly sildenafil, tadalafil, and/or vardenafil—either individually or in combination, at personalized dosages[1][2][3][5]. These medications work by inhibiting the enzyme PDE5, which leads to relaxation of blood vessels and increased blood flow to the penis during sexual stimulation, thereby facilitating erections[2][5]. Compounded to patient needs, Hims Hard Mints offer an alternative to standard pills, with potential for a faster onset due to chewable formulation, though they are not intended for sublingual absorption[1][5]. Because they are compounded, their specific formulation (ingredent(s) and strength) may vary but they always require clinical assessment and prescription by a licensed medical provider[2][5]. The product is made by Specialist Pharmacy in the UK and is distributed and prescribed through Hims, a telehealth company[2][7]. The medications are not FDA-approved as a combination/compounded product, but use FDA-approved pharmaceutical ingredients. Main indications are erectile dysfunction and, off-label, premature ejaculation[2].

Brand names
Hims Hard MintsHard Mints
Other names
Hims ED MintsHims chewable ED mints
02

Targets

PDE6 (Phosphodiesterase 6)PDE5 (Phosphodiesterase 5A)PDE11A (Phosphodiesterase 11A)

Beyond the preview

Go deeper on Hims Hard Mints.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hims Hard Mints.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call